Address
OrbiMed Advisors LLC
767 Third Avenue
30th Floor
New York, NY 10017
United States
Phone
Website
Recent investment activity
KANDO id: 29979
Corporate information
Founders
Official name
OrbiMed Advisors Limited Liability Company
Registration country
Company type
American investment firm focused on making public and private investments in the healthcare and biotechnology industries.Overview
OrbiMed invests globally across the healthcare industry, from start-ups to large multinational corporations, through a range of private equity funds, public equity funds, and royalty/credit funds. OrbiMed seeks to be a capital provider of choice, providing tailored financing solutions and extensive global team resources to help build world-class healthcare companies. OrbiMed’s team of over 100 professionals is based in New York City, San Francisco, Shanghai, Hong Kong, Mumbai, Herzliya, and other key global markets.
Funding rounds
Investment preferences
Investment focus themes
Top investment portfolio themes
Investment activity status
Active investor
Selected investments
Displaying 51 - 75 of 114Company | Profile | Country | Date | Funding | ||
---|---|---|---|---|---|---|
PharmAbcine Inc | Develops fully human therapeutic monoclonal antibody (mAb) | N/A | ||||
Pieris AG | Biopharmaceutical company. | N/A | ||||
Principia Biopharma | Discoverer and developer of differentiated small molecule drugs targeting inflammatory/autoimmune diseases as well as cancer. | N/A | ||||
Puma Biotechnology Inc | Biopharmaceutical company that acquires and develops innovative products. | N/A | ||||
RDD Pharma Ltd | Drug-device company that developed an intra-anal drug delivery device. | N/A | ||||
Realton Corp | Developer of a powerful and cost effective laser systems for use in the treatment of benign prostatic hyperplasia. | N/A | ||||
Receptos Inc [] | N/A | |||||
Relypsa Inc | Leads the discovery and development of new non-absorbed polymeric drugs | N/A | ||||
Rempex Pharmaceuticals Inc | Rempex Pharmaceuticals, Inc. is a San Diego-based pharmaceutical company. | N/A | ||||
Response Biomedical Corp | Commercializing a new class of diagnostic. | N/A | ||||
Roka Bioscience Inc | N/A | |||||
Selecta Biosciences Inc | A biotechnology company developing a new class of synthetic nanoparticle vaccines. | Series C | ||||
Selecta Biosciences Inc | A biotechnology company developing a new class of synthetic nanoparticle vaccines. | N/A | ||||
Senomyx Inc | Discovery and development of innovative flavor ingredients for the food, beverage, and ingredient supply industries | N/A | ||||
Shasun Pharmaceuticals Ltd | N/A | |||||
Sientra Inc | Medical device company | Series C | ||||
Singulex Inc | Provides immunoassay products and services. | N/A | ||||
Sonendo Inc | N/A | |||||
superDimension Ltd | Diagnose and potentially treat lung disease and lung cancer. | N/A | ||||
Supernus Pharmaceuticals Inc | N/A | |||||
Triangle Pharmaceuticals Inc | Anti-viral and oncology licensing company. | N/A | ||||
Vessix Vascular Inc | Developing novel radiofrequency balloon catheter technology. | N/A | ||||
ViewRay Inc [] | A medical device company, develops advanced radiation therapy solutions for the treatment of cancer. | N/A | ||||
ViewRay Inc [] | A medical device company, develops advanced radiation therapy solutions for the treatment of cancer. | N/A | ||||
Vivus Inc | N/A |